accountThe other three are Credit Suisse's (CSGN.VX Last year, Nycomed bought a majority stake in a Chinese pharmaceutical company, underscoring its focus on emerging markets and Western manufacturers' hunger to boost their presence in the country...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Takeda in talks with Nycomed, deal reportedly $14.2 billion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account